Optometrists in Fort Bragg, CA Accepting Medicare
5 Optometrists found. Showing 1 - 5
 J. Kyle Smith, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 450 N Mcpherson St, Fort Bragg, CA 95437 Phone: 707-964-5927 Fax: 707-964-6533 |
Elias Wolfman, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 139 Laurel St, Fort Bragg, CA 95437 Phone: 707-964-0919 |
 Lynette Kline O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 205 E Pine St, Fort Bragg, CA 95437 Phone: 707-961-1037 Fax: 707-961-0894 |
 Lynette Kline, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 510 Cypress St, Ste A, Fort Bragg, CA 95437 Phone: 707-961-1037 Fax: 707-961-0346 |
Dr. Elizabeth Hayes Harvey Optometrist Medicare: Accepting Medicare Assignments Practice Location: 501 S Franklin St, Fort Bragg, CA 95437 Phone: 707-964-6499 |
News Archive
Biologists spy close-up view of poliovirus linked to host cell receptor
Researchers from Purdue and Stony Brook universities have determined the precise atomic-scale structure of the poliovirus attached to key receptor molecules in human host cells and also have taken a vital snapshot of processes leading to infection.
Smokeless tobacco affects normal function of CYP-450 family of enzymes: Report
Far from having adverse effects limited to the mouth, smokeless tobacco affects the normal function of a key family of enzymes found in almost every organ in the body, according to the first report on the topic in ACS' monthly journal Chemical Research in Toxicology. The enzymes play important roles in production of hormones, including the sex hormones estrogen and testosterone; production of cholesterol and vitamin D; and help the body breakdown prescription drugs and potentially toxic substances.
Naltrexone-derived pyridomorphinan shows promise for treatment of alcoholism
Southern Research Institute and Gallo Research Center today announced that peer-reviewed results from a study testing Naltrexone-derived pyridomorphinan (SoRI-9409) will be published in the December 2008 issue of the journal Biological Psychiatry.
Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013
Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.
New drug target valid for breast cancer as well as lymphoma
One more piece of the puzzle has fallen into place behind a new drug whose anti-cancer potential was developed at the University of Alberta and is set to begin human trials this year, thanks to newly published research.
› Verified 9 days ago
Physical Therapists
Chiropractors
Optometrists
Occupational Therapists